Comparable recurrence risk for <scp>MRI</scp> ‐detected Gleason Grade Group (GG) <scp>2</scp> and systematic biopsy‐detected <scp>GG1</scp> prostate cancer
Year: 2025
Type: article
Language: en
Topic: Prostate Cancer Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Abderrahim‐Oussama Batouche
raw_affiliation_strings: Doctoral Program in Computer Science University of Helsinki  Helsinki Finland
ICAN‐Digital Precision Cancer Medicine Flagship  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland
raw_author_name: Eugen Czeizler
raw_affiliation_strings: ICAN‐Digital Precision Cancer Medicine Flagship  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki  Helsinki Finland
ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
raw_author_name: Timo‐Pekka Lehto
raw_affiliation_strings: ICAN‐Digital Precision Cancer Medicine Flagship  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland
raw_author_name: Andrew Erickson
raw_affiliation_strings: ICAN‐Digital Precision Cancer Medicine Flagship  Helsinki Finland
Nuffield Department of Surgical Sciences University of Oxford  Oxford UK
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki  Helsinki Finland
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
raw_author_name: Tolou Shadbahr
raw_affiliation_strings: ICAN‐Digital Precision Cancer Medicine Flagship  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland
raw_author_name: Teemu D. Laajala
raw_affiliation_strings: Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
raw_author_name: Joona Pohjonen
raw_affiliation_strings: ICAN‐Digital Precision Cancer Medicine Flagship  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki  Helsinki Finland
ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
raw_author_name: Tuomas Mirtti
raw_affiliation_strings: Department of Biomedical Engineering Emory University  Atlanta GA USA
Department of Pathology Helsinki University Hospital  Helsinki Finland
ICAN‐Digital Precision Cancer Medicine Flagship  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki  Helsinki Finland
ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Department of Biomedical Engineering, Emory University, Atlanta, GA, USA
Department of Pathology, Helsinki University Hospital, Helsinki, Finland
raw_author_name: Antti S. Rannikko
raw_affiliation_strings: Department of Urology Helsinki University Hospital  Helsinki Finland
ICAN‐Digital Precision Cancer Medicine Flagship  Helsinki Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine University of Helsinki  Helsinki Finland
ICAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland
Department of Urology, Helsinki University Hospital, Helsinki, Finland
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland